1. Home
  2. ELVN vs MRC Comparison

ELVN vs MRC Comparison

Compare ELVN & MRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • MRC
  • Stock Information
  • Founded
  • ELVN 2016
  • MRC 1921
  • Country
  • ELVN United States
  • MRC United States
  • Employees
  • ELVN N/A
  • MRC N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • MRC Industrial Machinery/Components
  • Sector
  • ELVN Health Care
  • MRC Industrials
  • Exchange
  • ELVN Nasdaq
  • MRC Nasdaq
  • Market Cap
  • ELVN 927.8M
  • MRC 1.0B
  • IPO Year
  • ELVN 2020
  • MRC 2012
  • Fundamental
  • Price
  • ELVN $18.42
  • MRC $12.26
  • Analyst Decision
  • ELVN Strong Buy
  • MRC Strong Buy
  • Analyst Count
  • ELVN 4
  • MRC 3
  • Target Price
  • ELVN $39.25
  • MRC $15.00
  • AVG Volume (30 Days)
  • ELVN 260.6K
  • MRC 692.3K
  • Earning Date
  • ELVN 05-13-2025
  • MRC 05-06-2025
  • Dividend Yield
  • ELVN N/A
  • MRC N/A
  • EPS Growth
  • ELVN N/A
  • MRC N/A
  • EPS
  • ELVN N/A
  • MRC N/A
  • Revenue
  • ELVN N/A
  • MRC $2,946,000,000.00
  • Revenue This Year
  • ELVN N/A
  • MRC $5.78
  • Revenue Next Year
  • ELVN N/A
  • MRC $7.19
  • P/E Ratio
  • ELVN N/A
  • MRC N/A
  • Revenue Growth
  • ELVN N/A
  • MRC N/A
  • 52 Week Low
  • ELVN $13.30
  • MRC $9.23
  • 52 Week High
  • ELVN $30.03
  • MRC $15.41
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 47.86
  • MRC 59.91
  • Support Level
  • ELVN $17.76
  • MRC $10.76
  • Resistance Level
  • ELVN $20.79
  • MRC $12.32
  • Average True Range (ATR)
  • ELVN 1.37
  • MRC 0.46
  • MACD
  • ELVN 0.12
  • MRC 0.13
  • Stochastic Oscillator
  • ELVN 45.39
  • MRC 88.14

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About MRC MRC Global Inc.

MRC Global Inc distributes pipes, valves, fittings, and other infrastructure products and services to diversified gas utility, energy, and industrial end-markets. It provides supply chain solutions, technical product service and a digital platform for customers globally. It offers a range of PVF, oilfield supply, valve automation and modification, measurement, instrumentation, and other general and specialty products. Its geographical segments include the United States and International. It generates the majority of its revenue from the United States.

Share on Social Networks: